Background: The serratus plane block is an effective technique for providing analgesia to patients undergoing breast surgery. Methods: This prospective, double-blind, randomized study enrolled 60 female patients scheduled for unilateral mastectomy and axillary clearance. The patients received either a superficial serratus plane block or deep serratus plane block. Dermatomal spread was recorded 30 minutes after block administration. Postoperatively, pain visual analog scale (VAS) scores were documented at recovery (time 0), at 30 minutes; and in the ward hourly for 4 hours, and 4-hourly until 24 hours postoperatively. The time to first analgesic rescue and cumulative morphine consumption using patient-controlled analgesia morphine (PCAM) were recorded. Results: The results showed lower VAS scores at rest (at 1, 2, 3, and 4 hours postoperatively), and during movement (at 1, 2, 3, 4, 8, and 24 hours postoperatively) in the superficial serratus plane block group, P < .005. Similarly, cumulative morphine usage was lower in the superficial serratus plane group, P < .005. The time to the first rescue analgesic was also significantly longer in the superficial group, P < .001. More patients in the superficial serratus plane group achieved greater dermatomal spread at T2 and T7 than those in the deep group. Conclusions: Superficial serratus plane block provides better analgesic efficacy than deep serratus plane block in mastectomy and axillary clearance.

A major adverse cardiac event (MACE) following non-cardiac surgery encompasses critical postoperative cardiovascular complications such as myocardial infarction or injury, cardiac arrest, or stroke that are associated with increased perioperative morbidity, mortality, and healthcare resource utilisation. Cardiac troponin (cTn), particularly high-sensitivity cardiac troponin (hs-cTn), has emerged as a key biomarker for prediction of MACE. Despite its recognised utility, there is no consensus on how cTn levels should be used for standardised postoperative surveillance. Interpretation of the cTn levels may vary depending on sex-specific reference values and baseline comorbidities such as chronic kidney disease, sepsis, critical illness, and non-ischaemic conditions. The balance between cost-effectiveness and clinical benefit in implementing universal versus targeted postoperative hs-cTn screening remains to be fully explored. This review examines the prognostic value of cardiac troponin (cTn) levels in predicting major adverse cardiovascular events (MACEs) in patients undergoing non-cardiac surgery, with a focus on perioperative cTn elevations—particularly those associated with myocardial injury after non-cardiac surgery (MINS)—as potential early indicators of increased cardiovascular risk.

Background: Shivering is described as an involuntary, repetitive activity of the skeletal muscles that can have deleterious effects on anaesthetized patients. This study aimed to evaluate the effectiveness of phenylephrine infusion in preventing perioperative shivering in patients undergoing lower segment cesarean section under spinal anesthesia and to observe the change in the patient’s core temperature between the study and control groups. Methods: A total of 118 patients scheduled for elective lower segment cesarean section under spinal anesthesia were recruited for this prospective, double-blind, randomized controlled study. The patients were randomized into 2 groups with 59 patients per group. The phenylephrine Group received phenylephrine infusion at a rate of 0.5 mcg/kg/minutes, while the Control Group received normal saline at an equivalent rate. Systolic and diastolic blood pressure, heart rate, core temperature, and the presence and intensity of shivering were recorded before induction and every 15 minutes intraoperatively and postoperatively. Results: The incidence of intraoperative shivering was significantly lower in the Phenylephrine Group compared to control group (29.1% vs 47.5% respectively; P = .044). Postoperatively, the Phenylephrine Group also had a lower incidence of shivering (34.5% vs 42.4%), but the difference was not statistically significant (P value = 0.391). There were no significant differences in the intensity of shivering between the 2 groups perioperatively, as well as in the systolic and diastolic blood pressure and core temperature. The phenylephrine Group showed a significantly lower heart rate at 15, 30, and 45 minutes after spinal block (P value = .005, .000, and .008, respectively), and at 0 and 30 minutes (P value = .004 and .020 respectively) in the recovery room. There were no significant differences in perioperative adverse events such as hypotension, hypertension, and bradycardia. Conclusion: Phenylephrine infusion reduces the incidence of perioperative shivering in lower segment cesarean sections under spinal anesthesia.

Background: A feeding tube (FT) is routinely placed in critically ill patients, and its correct placement is confirmed with a chest X-ray (CXR), which is considered the gold standard. This study evaluated the diagnostic accuracy of ultrasonography (USG) in verifying FT placement compared to a CXR in an intensive care unit (ICU). Method: This was a prospective single-blind study conducted on patients admitted to the ICU of a tertiary hospital in Malaysia. The FT placements were verified through a fogging test and USG at the neck and subxiphoid points. The results of confirmation of FT placement through USG were compared with those obtained using CXRs. Results: A total of 80 patients were included in this study. The FT positions were accurately confirmed by overall USG assessments in 71 patients. The percentage of FT placements correctly identified by neck USG was 97.5%, while the percentage of those identified by epigastric USG was 75%. The corresponding patients’ CXRs confirmed correct FT placement in 76 patients. The overall USG assessment had a sensitivity of 92.11% and specificity of 75%, a positive predictive value of 98.59%, and a negative predictive value of 33.33%. The USG findings also showed a significant association between FT size and BMI. FTs with a size of 14Fr were better visualized (p = 0.008), and negative USG findings had a significantly higher BMI (p < 0.001). Conclusion: USG is a simple, safe, and reliable bedside assessment that offers relatively high sensitivity in confirming correct FT placement in critically ill patients.

Background: Post-extubation hypoxaemia and postoperative pulmonary complications (PPCs) are common in surgical patients and contribute significantly to morbidity and prolonged recovery. High-flow nasal oxygen therapy (HFNOT) has been proposed as an alternative to conventional oxygen therapy (COT) in improving oxygenation and reducing PPCs postoperatively. Objectives: To evaluate the effectiveness of HFNOT compared to COT in reducing post-extubation hypoxaemia and PPCs in adult surgical patients, and to assess its impact on other clinical outcomes including ICU and hospital length of stay, mortality, and the need for escalation of respiratory support. Methods: A systematic review and meta-analysis of randomized controlled trials was conducted following PRISMA guidelines. Studies were identified from five databases including PubMed, Scopus, EBSCOHost, ProQuest, Ovid MEDLINE and Web of Science. Adult postoperative patients who received HFNOT after extubation were compared to those receiving COT. Primary outcomes included PaO₂/FiO₂ (PF) ratio and incidence of PPCs. Secondary outcomes were hospital and ICU length of stay, mortality, and need for escalation of therapy. Results: Seventeen trials comprising 1830 patients were included. HFNOT significantly improved PF ratio post-extubation and reduced the incidence of hypoxaemia and PPCs compared to COT. For secondary outcomes, HFNOT was associated with a reduced hospital length of stay and lower postoperative mortality, while no significant difference was found for ICU stay. Escalation of respiratory support was more frequent in the COT group. Subgroup analyses indicated greater improvements in oxygenation with HFNOT of shorter duration (<24 h) and in non-cardiothoracic patients. Conclusions: HFNOT is associated with improved postoperative oxygenation and a reduction in respiratory complications following extubation in surgical patients. The most pronounced benefits were observed in non-cardiothoracic populations and with short-duration applications. While the beneficial effects of HFNOT appear consistent across the included randomized controlled trials, further large-scale studies with standardized intervention durations, surgical populations, and clearly defined criteria for escalation of therapy are needed to strengthen and confirm these findings.

Approximately 75% of the world’s population lives in middle-income countries (MICs), where access to haemodynamic evaluation tools may be limited, exacerbating global healthcare disparities. We conducted an online survey of anaesthetists and intensivists working in MICs, inviting them to complete 15 questions on bedside haemodynamic evaluations and access to haemodynamic monitoring tools. We analysed 1593 valid questionnaires from 20 Upper and 19 Lower MICs. Most respondents (66%) worked in academic hospitals, 43% in private hospitals, and 20% in non-academic public hospitals. Respondents worked in ICUs (39%), operating rooms (38%), or both (23%). Nearly all had access to central venous catheters (99%) and invasive radial arterial pressure monitoring (91%). Fewer than two-thirds (63%) reported access to echocardiography, and only 37% had access to cardiac output monitoring systems when needed. The main barriers were the cost of monitors (54%) and the cost of disposable sensors (52%). Notably, 72% indicated they would use cardiac output monitoring equipment more frequently if costs were reduced. Most respondents (89%) reported a routine practice of predicting fluid responsiveness before giving a fluid bolus, most commonly with pulse pressure variation (64%) or ultrasound indices (55%). Tissue perfusion was mainly assessed by clinical evaluation (86%), blood lactate (81%), and capillary refill time (63%). In MICs, less than two-thirds of anaesthetists and intensivists reported having access to echocardiography for haemodynamic assessment. Fewer than 40% have access to cardiac output monitoring systems, mainly attributable to economic constraints. As this report represents a potential concerning equity gap in global healthcare, efforts should be made to prioritise and facilitate access to haemodynamic evaluation tools in MICs.